Powell Max appointed Geordan Pursglove as chairman and CEO. Pursglove is chairman and CEO of Lixte Biotechnology and managing director of 2GP Group. The company also added Andrew Hancox, Phillip Balatsos, Caroline Castleforte, and Lourdes Felix to its board. Hancox is founder and managing member of Block 8 Ventures, while Felix is CEO and CFO of BioCorRx.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Powell Max Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202603090830PRIMZONEFULLFEED9668033) on March 09, 2026, and is solely responsible for the information contained therein.
Comments